ASTELLAS PHARMA

🇯🇵Japan
Ownership
-
Established
2005-01-01
Employees
-
Market Cap
$22.5B
Website
https://www.astellas.com/

Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma

Phase 1
Completed
Conditions
Interventions
First Posted Date
2008-06-17
Last Posted Date
2013-04-15
Lead Sponsor
Astellas Pharma Inc
Target Recruit Count
128
Registration Number
NCT00698243
Locations
🇺🇸

Karmanos Cancer Institute, Detroit, Michigan, United States

🇧🇪

University Hospitals Leuven, Leuven, Belgium

🇬🇧

Royal Mardsen Hospital, Sutton, Surrey, United Kingdom

Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TX

First Posted Date
2008-06-09
Last Posted Date
2014-08-26
Lead Sponsor
Astellas Pharma Inc
Target Recruit Count
94
Registration Number
NCT00693524

Open-label Study to Evaluate Safety of Multiple Courses of IM Alefacept During Treatment of Chronic Plaque Psoriasis

Phase 3
Completed
Conditions
Interventions
First Posted Date
2008-06-06
Last Posted Date
2014-09-18
Lead Sponsor
Astellas Pharma Inc
Target Recruit Count
175
Registration Number
NCT00692172

Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis

Phase 3
Completed
Conditions
Interventions
First Posted Date
2008-06-05
Last Posted Date
2014-09-01
Lead Sponsor
Astellas Pharma Inc
Target Recruit Count
166
Registration Number
NCT00691262

Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis

Phase 3
Completed
Conditions
Interventions
First Posted Date
2008-06-05
Last Posted Date
2014-09-01
Lead Sponsor
Astellas Pharma Inc
Target Recruit Count
350
Registration Number
NCT00691145

Protopic Ointment in Children Atopic Eczema

First Posted Date
2008-06-04
Last Posted Date
2014-09-01
Lead Sponsor
Astellas Pharma Inc
Target Recruit Count
487
Registration Number
NCT00689832
© Copyright 2024. All Rights Reserved by MedPath